SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Total Non-Current Liabilities | ₹76 Cr | ₹176 Cr | ₹123 Cr | ₹138 Cr |
What is the latest Total Non-Current Liabilities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹76 Cr |
| Mar2025 | ₹176 Cr |
| Mar2024 | ₹123 Cr |
| Mar2023 | ₹138 Cr |
How is Total Non-Current Liabilities of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹76 Cr | -56.99 | |
| Mar2025 | ₹176 Cr | 43.07 | |
| Mar2024 | ₹123 Cr | -11.15 | |
| Mar2023 | ₹138 Cr | - | |
Compare Total Non-Current Liabilities of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹6,579.2 Cr | 6.6% | 7.6% | 42.2% | Stock Analytics | |
| PRIME FOCUS | ₹24,570.3 Cr | -10.8% | 4.1% | 73.1% | Stock Analytics | |
| SAGILITY | ₹20,317.0 Cr | -2.6% | 1.5% | -3.3% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹15,167.9 Cr | -1.9% | -8% | -42.9% | Stock Analytics | |
| INDEGENE | ₹14,770.1 Cr | 2.3% | 7% | 1.2% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹13,969.6 Cr | 2% | -5.3% | -12.4% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | 6.6% |
7.6% |
42.2% |
| SENSEX | -2.8% |
-6.1% |
-11.9% |
You may also like the below Video Courses